118 related articles for article (PubMed ID: 9522657)
1. [Hepatitis C virus (HCV) status in recipients transfused with blood from anti-HCV-positive donors].
Riisom K; Møller A
Ugeskr Laeger; 1998 Mar; 160(11):1637-9. PubMed ID: 9522657
[TBL] [Abstract][Full Text] [Related]
2. [Follow-up of blood donors with positive serology for hepatitis C virus and their recipients is insufficient].
Bonaguidi-Magniaux M; Pilette C; Oberti F; Bidet ML; Calès P
Gastroenterol Clin Biol; 1996; 20(8-9):663-8. PubMed ID: 8977814
[TBL] [Abstract][Full Text] [Related]
3. [Transfusion-related hepatitis C. The Danish "look back" survey].
Christensen PB; Grønbaek KE; Krarup HB
Ugeskr Laeger; 2000 May; 162(18):2554-7. PubMed ID: 10846954
[TBL] [Abstract][Full Text] [Related]
4. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
[TBL] [Abstract][Full Text] [Related]
5. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.
Foberg U; Ekermo B; Widell A; Mathiesen U; Fryden A
Scand J Infect Dis; 1996; 28(1):21-6. PubMed ID: 9122627
[TBL] [Abstract][Full Text] [Related]
7. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C lookback in Canada.
Goldman M; Long A
Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group.
Christensen PB; Groenbaek K; Krarup HB
Transfusion; 1999 Feb; 39(2):188-93. PubMed ID: 10037130
[TBL] [Abstract][Full Text] [Related]
11. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Makris K; Kouvelis V; Drakopoulos I; Oikonomou E; Maniatis A
Transfus Med; 1995 Sep; 5(3):213-24. PubMed ID: 8593527
[TBL] [Abstract][Full Text] [Related]
12. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
[TBL] [Abstract][Full Text] [Related]
13. Recent Canadian experience with targeted hepatitis C virus lookback.
Goldman M; Patterson L; Long A
Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
[TBL] [Abstract][Full Text] [Related]
14. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
15. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.
Norda R; Duberg AS; Sönnerborg A; Olcén P
Scand J Infect Dis; 1995; 27(5):449-52. PubMed ID: 8588133
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
[TBL] [Abstract][Full Text] [Related]
17. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors.
Smith BC; Chapman CE; Burt AD; Toms GL; Bassendine MF
QJM; 1997 Sep; 90(9):587-92. PubMed ID: 9349451
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C in blood transfusion recipients identified at the Oxford Blood Centre in the national HCV look-back programme.
Dike AE; Christie JM; Kurtz JB; Teo CG
Transfus Med; 1998 Jun; 8(2):87-95. PubMed ID: 9675784
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
Whitlock M; Lord S; Buxton JA; Doyle P; Bigham M
Transfusion; 2007 Aug; 47(8):1534-9. PubMed ID: 17655599
[TBL] [Abstract][Full Text] [Related]
20. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
Diekamp U; Kamutzky K; Windel CD
Beitr Infusionsther Transfusionsmed; 1997; 34():5-10. PubMed ID: 9417352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]